Recent Publications and Grants

Engaged in diverse basic, translational and clinical research, our faculty routinely publish in prestigious journals and successfully compete for major grants from national funders.

Recent Publications

Research Grants

  • Expanding the toolkit for design of robust phage therapeutic cocktails. Anne Kathryn Kauffman (Principal Investigator), Frank Scannapieco (Co-Investigator). NIH. $438,625. 12/1/2020-11/1/2022.
  • Environmental Health Scholar. Sarah Ventre (Principal Investigator). New York State Children’s Environmental Health Center. 11/1/2020-11/1/2022.
  • The Network Biology of Pathogen-Host Interactions Driving Exacerbation in Chronic Obstructive Pulmonary Disease (COPD). Manoj Mammen (Co-Investigator). Department of Defense, U.S. Army Medical Research and Materiel Command, Congressionally Directed Medical Research Programs. $1,057,527. 10/1/2020-8/1/2022.
  • Suramin for Radiation-Induced Oral Mucositis. Keith Kirkwood (Co-Principal Investigator). national Institutes of Health. $207,526. 9/1/2020-8/1/2022.
  • MTM 2: Collaborative Research: How does phage life history strategy govern predation in microbiomes?. Anne Kathryn Kauffman (Co-Investigator). NSF. $848,751. 9/1/2020-8/1/2025.
  • Antibody-based therapeutic to target RAGE. Ding Xu (Principal Investigator). Buffalo Innovation Accelerator Fund. $90,000. 9/1/2020-8/1/2021.
  • Planning for NIA R21/R33 Grant- Patient Driven Deprescribing to Enhance Successful Aging. Collin Clark (Co-Investigator), Christopher Daly (Co-Investigator), David Jacobs (Co-Investigator), Scott Monte (Co-Investigator), Ranjit Singh (Co-Principal Investigator), Robert Wahler (Co-Principal Investigator). US Deprescribing Research Network. $60,000. 8/1/2020-7/1/2021.
  • Identification of new or unrecognized virulence genes in hypervirulent Klebsiella pneumoniae and antivirulence genes in classical K. pneumoniae. Thomas Russo (Principal Investigator). NIH. $431,682. 8/1/2020-7/1/2022.
  • A Novel Approach to Bradycardia during Preterm Neonatal Resuscitation Using an Ovine Model of Asphyxia. Praveen Chandrasekharan (Principal Investigator). ZOLL Foundation. $50,000. 7/1/2020-7/1/2022.
  • Comparison of triple therapy with apixaban vs. rivaroxabn. Maya Chilbert (Principal Investigator), David Jacobs (Co-Investigator), Ashley Woodruff (Co-Investigator). American College of Clinical Pharmacy Cardiology PRN. 7/1/2020-6/1/2021.
  • Treatment of Periodontitis by Homing M2 Macrophages. Patricia Diaz (Co-Investigator). NIH. 7/1/2020-6/1/2025.
  • ACCP Cardiology PRN Seed Grant. Maya Chilbert (Principal Investigator). American College of Clinical Pharmacy. $5,000. 7/1/2020-6/1/2021.
  • A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study. Ajay Chaudhuri (Principal Investigator). Spruce Biosciences. 7/1/2020-7/1/2021.
  • Genetic susceptibility to mucosal infections with aging. Elsa Bou Ghanem (Co-Principal Investigator). NIAID-R21. $438,625. 6/1/2020-5/1/2022.
  • Mitochondrial dynamics in SARS-CoV-2 spike protein treated human CNS cells: Implications for COVID19 induced CNS hypoxia. Supriya Mahajan (Principal Investigator). SUNY Research Seed Grant Program. $5,000. 6/1/2020-10/1/2020.